Zimmer Biomet Holdings (ZBH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 905,200 | 1,025,100 | 291,200 | 445,500 | -9,200 |
| Depreciation Amortization | 996,300 | 951,700 | 1,219,200 | 954,000 | 1,401,400 |
| Income taxes - deferred | -47,700 | -96,300 | -64,400 | -102,100 | 39,400 |
| Accounts receivable | -89,700 | -51,900 | -184,700 | -40,800 | -66,200 |
| Other Working Capital | -455,400 | -396,200 | -311,400 | -134,200 | -429,800 |
| Other Operating Activity | 190,700 | 149,200 | 406,300 | 281,900 | 140,000 |
| Operating Cash Flow | $1,499,400 | $1,581,600 | $1,356,200 | $1,404,300 | $1,075,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -444,100 | -602,800 | -446,200 | -417,200 | -370,900 |
| Net Acquisitions | -276,300 | -134,900 | -99,800 | N/A | -227,100 |
| Purchase Sale Intangibles | -153,000 | -103,400 | -29,700 | -8,400 | N/A |
| Other Investing Activity | -167,700 | -41,200 | 24,000 | -26,100 | 33,700 |
| Investing Cash Flow | $-888,100 | $-778,900 | $-522,000 | $-443,300 | $-564,300 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,436,300 | 499,800 | 83,000 | 1,599,800 | 1,497,100 |
| Debt Repayment | -900,000 | -445,200 | -1,143,700 | -2,654,800 | -1,750,000 |
| Common Stock Issued | 82,100 | 101,100 | 78,100 | 122,500 | 129,800 |
| Common Stock Repurchased | -868,000 | -692,200 | -126,400 | N/A | 0 |
| Dividend Paid | -196,000 | -200,900 | -201,200 | -200,100 | -198,500 |
| Other Financing Activity | -38,900 | -26,100 | 534,500 | -173,400 | -98,600 |
| Financing Cash Flow | $-484,500 | $-763,500 | $-775,700 | $-1,306,000 | $-420,200 |
| Exchange Rate Effect | -17,100 | 900 | -14,500 | -13,200 | 15,300 |
| Beginning Cash Position | 415,800 | 375,700 | 478,500 | 802,100 | 617,900 |
| End Cash Position | 525,500 | 415,800 | 375,700 | 478,500 | 802,100 |
| Net Cash Flow | $109,700 | $40,100 | $-102,800 | $-323,600 | $184,200 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,499,400 | 1,581,600 | 1,356,200 | 1,404,300 | 1,075,600 |
| Capital Expenditure | -444,100 | -602,800 | -446,200 | -417,200 | -370,900 |
| Free Cash Flow | 1,055,300 | 978,800 | 910,000 | 987,100 | 704,700 |